Burnside; Beth A.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Burnside; Beth A..The latest application filed is for "disposal of medicaments".
Company Profile
2.46.40
- Burnside; Beth A. - Kilmarnock VA
- Burnside; Beth A. - Bethesda MD US
- Burnside, Beth A. - Silver Spring MD
- Burnside; Beth A. - Brookeville MD
- Burnside; Beth A. - Silver Springs MD
Patent Activity
| Patent | Date |
|---|---|
| Disposal of medicaments Grant 10,532,385 - Schestopol , et al. Ja | 2020-01-14 |
| Disposal Of Medicaments App 20190358687 - Schestopol; Marcus ; et al. | 2019-11-28 |
| Disposal Of Medicaments App 20180001357 - SCHESTOPOL; MARCUS ; et al. | 2018-01-04 |
| Antibiotic product, use and formulation thereof Grant 9,144,548 - Burnside , et al. September 29, 2 | 2015-09-29 |
| Drug formulations having reduced abuse potential Grant 9,144,551 - Chang , et al. September 29, 2 | 2015-09-29 |
| Gastric release pulse system for drug delivery Grant 9,125,803 - Flanner , et al. September 8, 2 | 2015-09-08 |
| Drug Formulations Having Reduced Abuse Potential App 20150150816 - CHANG; Rong-Kun ; et al. | 2015-06-04 |
| Drug formulations having reduced abuse potential Grant 8,906,413 - Chang , et al. December 9, 2 | 2014-12-09 |
| Tablet For Pulsed Delivery App 20140212490 - Cao; Bruce ; et al. | 2014-07-31 |
| Modified release amoxicillin products Grant 8,778,924 - Flanner , et al. July 15, 2 | 2014-07-15 |
| Device for Disposing Medicament Products App 20140183070 - Holaday; John W. ; et al. | 2014-07-03 |
| Device for Disposal and Neutralization of Pharmaceutical Agents App 20140187842 - Holaday; John W. ; et al. | 2014-07-03 |
| Robust pellet Grant 8,758,820 - Cao , et al. June 24, 2 | 2014-06-24 |
| Tablet for pulsed delivery Grant 8,715,727 - Cao , et al. May 6, 2 | 2014-05-06 |
| Antibiotic product, use and formulation thereof Grant 8,460,710 - Burnside , et al. June 11, 2 | 2013-06-11 |
| Antibiotic product, use and formulation thereof Grant 8,425,936 - Burnside , et al. April 23, 2 | 2013-04-23 |
| Compositions and methods for improved efficacy of penicillin-type antibiotics Grant 8,357,394 - Flanner , et al. January 22, 2 | 2013-01-22 |
| Antibiotic product, use and formulation thereof Grant 8,313,775 - Burnside , et al. November 20, 2 | 2012-11-20 |
| Antibiotic product, use and formulation thereof Grant 8,313,776 - Burnside , et al. November 20, 2 | 2012-11-20 |
| Pharmaceutical compositions and methods for improved bacterial eradication Grant 8,299,052 - Flanner , et al. October 30, 2 | 2012-10-30 |
| Antibiotic Product, Use And Formulation Thereof App 20120213825 - Burnside; Beth A. ; et al. | 2012-08-23 |
| Antibiotic product, use and formulation thereof Grant 8,246,996 - Burnside , et al. August 21, 2 | 2012-08-21 |
| Antibiotic product, use and formulation thereof Grant 8,062,672 - Burnside , et al. November 22, 2 | 2011-11-22 |
| Oral pulsed dose drug delivery system Grant RE42,096 - Burnside , et al. February 1, 2 | 2011-02-01 |
| Once-A-Day RNA-Polymerase inhibiting and elongation factor G (EF-G) inhibiting antibiotic pharmaceutical product, formulation thereof, and use thereof in treating infection caused by methicillin-resistant staphylococcus aureus App 20100120896 - Sander; Sanna ; et al. | 2010-05-13 |
| Oral pulsed dose drug delivery system Grant RE41,148 - Burnside , et al. February 23, 2 | 2010-02-23 |
| Once-a-day (RNA-Polymerase Inhibiting or phenazine) - dihydropteroate synthase inhibiting - dihydrofolate reductase inhibiting antibiotic pharmaceutical product, formulation thereof, and use thereof in treating infection caused by Methicillin-Resistant Staphylococcus aureus App 20100016333 - Flanner; Henry H. ; et al. | 2010-01-21 |
| Modified release dosage forms of amoxicillin App 20080139526 - Treacy; Donald ; et al. | 2008-06-12 |
| Modified release amoxicillin products App 20080132478 - Flanner; Henry H. ; et al. | 2008-06-05 |
| Pharmaceutical compositions and methods for improved bacterial eradication App 20080050430 - Flanner; Henry H. ; et al. | 2008-02-28 |
| Gastric release pulse system for drug delivery App 20070154547 - Flanner; Henry H. ; et al. | 2007-07-05 |
| Compositions and methods for improved efficacy of penicillin-type antibiotics App 20070134327 - Flanner; Henry H. ; et al. | 2007-06-14 |
| Extended release formulations of poorly soluble antibiotics App 20060193908 - Burnside; Beth A. ; et al. | 2006-08-31 |
| Self-emulsifying formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability and/or reduced food effect Grant 7,022,337 - Liang , et al. April 4, 2 | 2006-04-04 |
| Oral capsule formulation with increased physical stability Grant 7,011,846 - Shojaei , et al. March 14, 2 | 2006-03-14 |
| Tablet for pulsed delivery App 20060003005 - Cao; Bruce ; et al. | 2006-01-05 |
| Sustained release delivery of amphetamine salts Grant 6,913,768 - Couch , et al. July 5, 2 | 2005-07-05 |
| Enhanced absorption of modified release dosage forms App 20050142187 - Treacy, Donald J. JR. ; et al. | 2005-06-30 |
| Antibiotic product, use and formulation thereof App 20050058708 - Burnside, Beth A. ; et al. | 2005-03-17 |
| Antibiotic product, use and formulation thereof App 20050048114 - Burnside, Beth A. ; et al. | 2005-03-03 |
| Antibiotic product, use and formulation thereof App 20050037076 - Burnside, Beth A. ; et al. | 2005-02-17 |
| Robust pellet App 20050037071 - Cao, Bruce X. ; et al. | 2005-02-17 |
| Antibiotic product, use and formulation thereof App 20050019402 - Burnside, Beth A. ; et al. | 2005-01-27 |
| Antibiotic product, use and formulation thereof App 20050019401 - Burnside, Beth A. ; et al. | 2005-01-27 |
| Antibiotic product, use and formulation thereof App 20050019403 - Burnside, Beth A. ; et al. | 2005-01-27 |
| System for osmotic delivery of pharmaceutically active agents Grant 6,838,093 - Flanner , et al. January 4, 2 | 2005-01-04 |
| Pulsatile transdermally administered antigens and adjuvants App 20040253249 - Rudnic, Edward M. ; et al. | 2004-12-16 |
| Drug formulations having reduced abuse potential App 20040228802 - Chang, Rong-Kun ; et al. | 2004-11-18 |
| Osmotic drug delivery system Grant 6,814,979 - Rudnic , et al. November 9, 2 | 2004-11-09 |
| Oral pulsed dose drug delivery system App 20040219213 - Burnside, Beth A. ; et al. | 2004-11-04 |
| Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles Grant 6,811,794 - Burnside , et al. November 2, 2 | 2004-11-02 |
| Solid oral dosage form Grant 6,793,934 - Burnside , et al. September 21, 2 | 2004-09-21 |
| Self-emulsifying formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability and/or reduced food effect App 20040110842 - Liang, Likan ; et al. | 2004-06-10 |
| Sustained release pharmaceutical dosage forms with minimized ph dependent dissolution profiles App 20040062800 - Burnside, Beth A. ; et al. | 2004-04-01 |
| Solid solution beadlet Grant 6,692,767 - Burnside , et al. February 17, 2 | 2004-02-17 |
| Pharmaceutical formulations with improved bioavailability App 20040028729 - Shojaei, Amir H. ; et al. | 2004-02-12 |
| Formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability App 20040005339 - Shojaei, Amir H. ; et al. | 2004-01-08 |
| Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles App 20030158261 - Burnside, Beth A. ; et al. | 2003-08-21 |
| Oral pulsed dose drug delivery system Grant 6,605,300 - Burnside , et al. August 12, 2 | 2003-08-12 |
| Soluble form osmotic dose delivery system App 20030143273 - Rudnic, Edward M. ; et al. | 2003-07-31 |
| Oral capsule formulation with increased physical stability App 20030124182 - Shojaei, Amir H. ; et al. | 2003-07-03 |
| Oral pulsed dose drug delivery system App 20030124188 - Burnside, Beth A. ; et al. | 2003-07-03 |
| Pharmaceutical compositions including sampatrilat dispersed in a lipoidic vehicle App 20030065040 - Shojaei, Amir H. ; et al. | 2003-04-03 |
| Soluble form osmotic dose delivery system Grant 6,514,532 - Rudnic , et al. February 4, 2 | 2003-02-04 |
| System for osmotic delivery of pharmaceutically active agents App 20030003150 - Burnside, Beth A. ; et al. | 2003-01-02 |
| Soluble form osmotic dose delivery system App 20020102306 - Rudnic, Edward M. ; et al. | 2002-08-01 |
| Soluble form osmotic dose delivery system Grant 6,361,796 - Rudnic , et al. March 26, 2 | 2002-03-26 |
| Oral Pulsed Dose Drug Delivery System App 20010055613 - BURNSIDE, BETH A. ; et al. | 2001-12-27 |
| Oral pulsed dose drug delivery system Grant 6,322,819 - Burnside , et al. November 27, 2 | 2001-11-27 |
| Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles Grant 6,287,599 - Burnside , et al. September 11, 2 | 2001-09-11 |
| Soluble form osmotic dose delivery system Grant 6,284,276 - Rudnic , et al. September 4, 2 | 2001-09-04 |
| Solid Solution Beadlet App 20010006650 - BURNSIDE, BETH A. ; et al. | 2001-07-05 |
| Osmotic drug delivery system Grant 6,110,498 - Rudnic , et al. August 29, 2 | 2000-08-29 |
| Oral induction of tolerance to parenterally administered non-autologous polypeptides Grant 5,948,407 - McGuinness , et al. September 7, 1 | 1999-09-07 |
| Emulsified drug delivery system Grant 5,897,876 - Rudnic , et al. April 27, 1 | 1999-04-27 |
| Oral acyclovir delivery Grant 5,883,103 - Burnside , et al. March 16, 1 | 1999-03-16 |
| Oral insulin delivery Grant 5,824,638 - Burnside , et al. October 20, 1 | 1998-10-20 |
Company Registrations
| SEC | 0001263493 | BURNSIDE BETH A |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 